Disseminated tuberculosis after anti-TNFα treatment

被引：21

作者：

Malipeddi, Aruna S. ^{[1
]}

Kallarackal, George ^{[1
]}

机构：

[1] Gen Hosp Kettering, Dept Rheumatol, Kettering NN16 8UZ, England

来源：

LANCET | 2007年 / 369卷 / 9556期

关键词：

D O I：

10.1016/S0140-6736(07)60078-6

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：162 / 162

页数：1

共 5 条

[1] Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis:: a prospective study [J].

Ferrara, G ;

Losi, M ;

D'Amico, R ;

Roversi, P ;

Piro, R ;

Meacci, M ;

Meccugni, B ;

Dori, IM ;

Andreani, A ;

Bergamini, BM ;

Mussini, C ;

Rumpianesi, F ;

Fabbri, LM ;

Richeldi, L .

LANCET, 2006, 367 (9519) :1328-1334

[2] Tuberculosis associated with infliximab, a tumor necrosis factor (alpha)-neutralizing agent [J].

Keane, J ;

Gershon, S ;

Wise, RP ;

Mirabile-Levens, E ;

Kasznica, J ;

Schwieterman, WD ;

Siegel, JN ;

Braun, MM .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (15) :1098-1104

[3] Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor [J].

Mohan, AK ;

Coté, TR ;

Block, JA ;

Manadan, AM ;

Siegel, JN ;

Braun, MM .

CLINICAL INFECTIOUS DISEASES, 2004, 39 (03) :295-299

[4] BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-α treatment [J].

Ormerod, LP ;

Milburn, HJ ;

Gillespie, S ;

Ledingham, J ;

Rampton, D .

THORAX, 2005, 60 (10) :800-805

[5] Safety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis [J].

Schiff, M. H. ;

Burmester, G. R. ;

Kent, J. D. ;

Pangan, A. L. ;

Kupper, H. ;

Fitzpatrick, S. B. ;

Donovan, C. .

ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (07) :889-894

← 1 →